Outset Medical (OM) EV/EBITDA Multiple

Graphic logo of Outset (OM)

Outset Medical, Inc. (OM) develops Tablo portable blood purification systems, targeting clinics and private users. Management is currently actively restoring trade cycles following regulatory delays, gradually increasing shipments. This chart of stock quotes demonstrates an EV/EBITDA of 0.00. Outset Medical, Inc. (OM) transformed hemodialysis by introducing a compact digital device that automates solution preparation for home use.

OM (Outset) Business Value to Operating Income Before Depreciation history from 11/23/2025 to 11/10/2026

OM (outsetmedical.com): analytical breakdowns and indicator data

- current price and projected stock value:
Stock Price Outset|OM - Analyst Median Target
- market capitalization details:
Market Capitalization Outset Medical Corp|OM - Real Price to Acquire Entire Company
- issuer book value statistics:
Accounting Value per Share Outset Medical|OM - Accounting Value of Company|Market Value to Book Value Ratio outsetmedical.com|OM - Cumulative Company Assets
- debt level and financial liquidity data:
Total Debt to Capital Outset Medical, Inc.|OM - Long-Term Liabilities to Capital|Short-Term Debt to Capital Outset Medical|OM - Company Aggregate Debt|Debts to Book Capitalization Outset Medical Corp|OM - Long-Term Debt Volume|Company Short-Term Debts Outset Medical|Quick Ratio outsetmedical.com
- net income and valuation multiples indicators:
OM - Net Profit|Expected Profit Outset Medical, Inc.|OM - Price to Earnings Ratio|Projected Price to Earnings Outset Medical, Inc.|OM - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Outset Medical Corp|OM - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Outset Medical|OM - Net earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months outsetmedical.com|OM - Earnings growth in current year|Earnings growth forecast for next year Outset Medical, Inc.
Fundamental company valuation:Outset OM
Product sample of outsetmedical.com

The loyalty of biomedical engineers at Outset Medical, Inc. (OM) ensures the stability of dialysis system development, laying the foundation for operational efficiency. The ratio of total enterprise value to earnings before interest, taxes, depreciation, and amortization, as shown on this EV/EBITDA chart, determines the asset's real value inclusive of debt. Analyzing the historical lows of this metric helps investors identify points of company undervaluation. Current price action on the chart allows for an assessment of whether the market capitalization is fair relative to the generated cash flow.

Analysis of competing companies

EV/EBITDA Multiple DXCM (Dexcom Corp)|Total Company Value to Operating Income Before Depreciation Ratio Penumbra Medical (PEN)|Novanta Inc. - EV/EBITDA Multiple|haemonetics.com (HAE) - Enterprise Value to EBITDA Ratio|INSP (Inspire Medical Systems, Inc.) - Enterprise Value to EBITDA Ratio|PROCEPT BioRobotics Corp - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CONMED Corp.|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|EV/EBITDA Multiple INMD|PMI - Company Value to EBITDA|EV/EBITDA Multiple SRDX (Surmodics)|SENS: Enterprise Value to Operating Income Before Depreciation|NeuroPace Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Tactile Systems Technology TCMD|SNWV: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Electromed|LNSR (LENSAR) - EV/EBITDA Multiple|EV/EBITDA Multiple AVITA Medical Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Profound Medical Corp. (PROF)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BDMD (bairdmed.com)|EDAP TMS - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation APYX|IceCure Medical, Ltd. - EV/EBITDA Multiple|Company Value to EBITDA Pulmonx Corporation|telabio.com (TELA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Multiple CytoSorbents Corporation CTSO|Enterprise Value to EBITDA Ratio SRTS|EV/EBITDA Multiple zynex.com|EV/EBITDA Multiple ECOR|Total Company Value to Operating Income Before Depreciation Ratio vicarioussurgical.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Inspira Technologies IINN|ICU (SeaStar Medical Holding Corp.) - Company Value to Operating Income Before Depreciation Ratio|IRIX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Intelligent Bio Solutions (INBS) - Enterprise Value to EBITDA Ratio|XAIR: EV/EBITDA Multiple|Company Value to EBITDA Profusa Inc. (PFSA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to Operating Income Before Depreciation GCTK (GlucoTrack Inc.)|Enterprise Value to EBITDA Ratio NAOV (NanoVibronix, Inc.)|Enterprise Value to Operating Income Before Depreciation Ratio VERO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|Aethlon Medical Inc (AEMD) - Company Value to EBITDA|ASXC: Enterprise Value to EBITDA Ratio|AVGR - EV/EBITDA Multiple|BSGM (BioSig Technologies, Inc.) - Enterprise Value to EBITDA Ratio|CUTR: Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Know Labs|Inari Medical Inc (NARI) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple NVRO|RSLS - Company Value to EBITDA|Silk Road Medical, Inc - Enterprise Value to EBITDA Ratio